Change Healthcare Inc. Research and Development Expense
Change Healthcare Inc. reported Research and Development Expense of $74.20 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-08-04
- Change Healthcare Inc. research and development expense for the quarter ending 2022-06-30 was $74.20M, a 4.15% increase year-over-year.
- Change Healthcare Inc. research and development expense for the quarter ending 2022-03-31 was $72.31M, a 22.71% increase year-over-year.
- Change Healthcare Inc. research and development expense for the quarter ending 2021-12-31 was $67.31M, a 15.42% increase year-over-year.
- Change Healthcare Inc. research and development expense for the quarter ending 2021-09-30 was $67.07M, a 24.08% increase year-over-year.
- Change Healthcare Inc. research and development expense for fiscal 2022 was $277.93M, a 22.42% increase from fiscal 2021.
- Change Healthcare Inc. research and development expense for fiscal 2021 was $227.04M, a 1864.15% increase from fiscal 2020.
- Change Healthcare Inc. research and development expense for fiscal 2020 was $11.56M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $74.20M 10-Q · filed 2022-08-04 | $146.50M derived: sum of 2 quarters · filed 2022-08-04 | $213.82M derived: sum of 3 quarters · filed 2022-08-04 | $280.89M derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | $72.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-26 | $139.62M derived: sum of 2 quarters · filed 2022-05-26 | $206.69M derived: sum of 3 quarters · filed 2022-05-26 | $277.93M 10-K · filed 2022-05-26 |
| 2021-12-31 | $67.31M 10-Q · filed 2022-02-03 | $134.38M derived: sum of 2 quarters · filed 2022-02-03 | $205.62M 10-Q · filed 2022-02-03 | $264.55M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-09-30 | $67.07M 10-Q · filed 2021-11-04 | $138.31M 10-Q · filed 2021-11-04 | $197.24M derived: sum of 3 quarters · filed 2022-08-04 | $255.56M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-06-30 | $71.24M 10-Q · filed 2022-08-04 | $130.17M derived: sum of 2 quarters · filed 2022-08-04 | $188.49M derived: sum of 3 quarters · filed 2022-08-04 | $242.54M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $58.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-26 | $117.25M derived: sum of 2 quarters · filed 2022-05-26 | $171.30M derived: sum of 3 quarters · filed 2022-05-26 | $227.04M 10-K · filed 2022-05-26 |
| 2020-12-31 | $58.32M 10-Q · filed 2022-02-03 | $112.38M derived: sum of 2 quarters · filed 2022-02-03 | $168.11M 10-Q · filed 2022-02-03 | |
| 2020-09-30 | $54.05M 10-Q · filed 2021-11-04 | $109.79M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $55.73M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $11.56M 10-K · filed 2022-05-26 |